Intracellular PD-L1: Functions, Regulation, and Therapeutic Implications

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Programmed death-ligand 1 (PD-L1) is a key immune checkpoint target in cancer immunotherapy.
• Current PD-1/PD-L1 therapies face limitations like resistance and low response rates.
• Emerging evidence suggests PD-L1 has functions beyond its membrane-bound immune role.

Purpose of the Study:

• To review the subcellular localization of PD-L1.
• To examine the mechanisms of PD-L1 trafficking and compartmentalization.
• To explore the compartment-specific functions and clinical significance of PD-L1.

Main Methods:

• Literature review of studies on PD-L1 subcellular localization.
• Analysis of research on PD-L1 trafficking and compartmentalization mechanisms.
• Synthesis of data on PD-L1's diverse biological functions and clinical implications.

Main Results:

• PD-L1 is found in cytoplasm, nucleus, organelles, and extracellular vesicles, not just the cell membrane.
• Intracellular PD-L1 populations exhibit immune-independent functions, including transcriptional regulation and DNA damage response modulation.
• These diverse roles suggest non-canonical functions impacting cellular processes.

Conclusions:

• A comprehensive understanding of PD-L1's full biological spectrum, including intracellular roles, is crucial.
• Targeting diverse PD-L1 pools may overcome current immunotherapy limitations.
• Exploring non-canonical PD-L1 functions can lead to novel therapeutic strategies and personalized medicine.